logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CAPITAL GRAND (01329) is issuing approximately 104 million shares of convertible preferred stock permanently.

date
09:00 06/01/2025
avatar
GMT Eight
Original: (01329)202513Sma... Chuangjiu (01329) announced on January 3, 2025, that the company issued and distributed common stock to enable Sma...
Announcement from CAPITAL GRAND (01329): On January 3, 2025, the company issued and distributed common stock to Smart Win Group Limited in order to convert approximately HK$218 million worth of convertible securities into approximately 104 million shares, at an issue price of HK$2.1 per share.
Related Articles
HK Stock
FIRST CAP GP(01269) releases annual performance, with a net loss of 342 million yuan attributable to shareholders, a year-on-year decrease of 13.1%
HK Stock
ASCENTAGE-B (06855) Achieves high growth with dual-engine drive, with Naike's sales increasing by 81% year-on-year.
HK Stock
EVEREST MED (01952) releases annual performance: revenue of 1.707 billion, a year-on-year increase of 141.51%; sales of Nephrocaps drive strong growth.
FIRST CAP GP(01269) releases annual performance, with a net loss of 342 million yuan attributable to shareholders, a year-on-year decrease of 13.1%
HK Stock
ASCENTAGE-B (06855) Achieves high growth with dual-engine drive, with Naike's sales increasing by 81% year-on-year.
HK Stock
EVEREST MED (01952) releases annual performance: revenue of 1.707 billion, a year-on-year increase of 141.51%; sales of Nephrocaps drive strong growth.
HK Stock
RECOMMEND
“Lobster” Contained: Why The Financial Sector Is Reluctant To Adopt It
“Lobster” Contained: Why The Financial Sector Is Reluctant To Adopt It
icon
25/03/2026
Hong Kong AI New Narrative: Embracing Token Economics
Hong Kong AI New Narrative: Embracing Token Economics
icon
25/03/2026
Is The Spring For Pharma Stocks Here? WuXi AppTec Rises Over 9% As Institutions Back An Industry Inflection
Is The Spring For Pharma Stocks Here? WuXi AppTec Rises Over 9% As Institutions Back An Industry Inflection
icon
25/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.